{
    "organizations": [],
    "uuid": "d7ebb023959f778533ba1d130c55b5e20bed85e6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cleveland-biolabs-reports-qtrly-lo/brief-cleveland-biolabs-reports-qtrly-loss-per-share-0-10-idUSFWN1QO0MA",
    "ord_in_thread": 0,
    "title": "BRIEF-Cleveland Biolabs Reports Qtrly Loss Per Share $0.10‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Cleveland Biolabs Inc:\n* CLEVELAND BIOLABS INC - QTRLY LOSS PER SHARE $0.10‍​\n* CLEVELAND BIOLABS-ESTIMATES CASH,CASH EQUIVALENTS,SHORT-TERM INVESTMENTS AS OF DEC 31 ENOUGH TO FUND OPERATIONS FOR AT LEAST 1 YEAR AFTER 10-K FILING DATE Source text: ( bit.ly/2FXHEdA ) Further company coverage:\n ",
    "published": "2018-03-06T21:14:00.000+02:00",
    "crawled": "2018-03-07T19:23:46.028+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "cleveland",
        "biolabs",
        "inc",
        "cleveland",
        "biolabs",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "cleveland",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "dec",
        "enough",
        "fund",
        "operation",
        "least",
        "year",
        "filing",
        "date",
        "source",
        "text",
        "company",
        "coverage"
    ]
}